CrossrefInfokarte
Comparative Effectiveness and Safety of Upadacitinib vs Risankizumab for Ulcerative Colitis
Clinical Gastroenterology and Hepatology · 2026-11 · 24 (11) · 3157-3159
DOI: 10.1016/j.cgh.2026.01.032 ↗Abstract
Kein Abstract verfügbar.
EUVIMED